Insider Trading & Ownership of Peter G. Traber

Location
Houston, TX
Summary
The estimated net worth of Peter G. Traber is at least $1,376,840 dollars as of 26 Sep 2023. Peter G. Traber is the Chief Medical Officer of SELECTA BIOSCIENCES INC and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $930.8K. Peter G. Traber is the Director of CALADRIUS BIOSCIENCES, INC. and owns shares of LISATA THERAPEUTICS, INC. (LSTA) stock worth about $446.1K.
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Peter G. Traber and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Peter G. Traber has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,376,840.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: SELECTA BIOSCIENCES INC ($930,762).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Peter G. Traber

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RNAC SELECTA BIOSCIENCES INC Chief Medical Officer $930,762 25 Sep 2023
LSTA CALADRIUS BIOSCIENCES, INC. Director $446,078 10 Jan 2022

Insider Transactions Reported by Peter G. Traber:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .